Cargando…

P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer

BACKGROUND: Fascin is crucial for cancer cell filopodium formation and tumor metastasis, and is functionally regulated by post‐translational modifications. However, whether and how Fascin is regulated by acetylation remains unclear. This study explored the regulation of Fascin acetylation and its co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yin‐Wei, Zeng, Fa‐Min, Li, Da‐Jia, Wang, Shao‐Hong, He, Jian‐Zhong, Guo, Zhen‐Chang, Nie, Ping‐Juan, Wu, Zhi‐Yong, Shi, Wen‐Qi, Wen, Bing, Xu, Xiu‐E, Liao, Lian‐Di, Li, Zhi‐Mao, Wu, Jian‐Yi, Zhan, Jun, Zhang, Hong‐Quan, Chang, Zhi‐Jie, Zhang, Kai, Xu, Li‐Yan, Li, En‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696220/
https://www.ncbi.nlm.nih.gov/pubmed/34555274
http://dx.doi.org/10.1002/cac2.12221
_version_ 1784619759070871552
author Cheng, Yin‐Wei
Zeng, Fa‐Min
Li, Da‐Jia
Wang, Shao‐Hong
He, Jian‐Zhong
Guo, Zhen‐Chang
Nie, Ping‐Juan
Wu, Zhi‐Yong
Shi, Wen‐Qi
Wen, Bing
Xu, Xiu‐E
Liao, Lian‐Di
Li, Zhi‐Mao
Wu, Jian‐Yi
Zhan, Jun
Zhang, Hong‐Quan
Chang, Zhi‐Jie
Zhang, Kai
Xu, Li‐Yan
Li, En‐Min
author_facet Cheng, Yin‐Wei
Zeng, Fa‐Min
Li, Da‐Jia
Wang, Shao‐Hong
He, Jian‐Zhong
Guo, Zhen‐Chang
Nie, Ping‐Juan
Wu, Zhi‐Yong
Shi, Wen‐Qi
Wen, Bing
Xu, Xiu‐E
Liao, Lian‐Di
Li, Zhi‐Mao
Wu, Jian‐Yi
Zhan, Jun
Zhang, Hong‐Quan
Chang, Zhi‐Jie
Zhang, Kai
Xu, Li‐Yan
Li, En‐Min
author_sort Cheng, Yin‐Wei
collection PubMed
description BACKGROUND: Fascin is crucial for cancer cell filopodium formation and tumor metastasis, and is functionally regulated by post‐translational modifications. However, whether and how Fascin is regulated by acetylation remains unclear. This study explored the regulation of Fascin acetylation and its corresponding roles in filopodium formation and tumor metastasis. METHODS: Immunoprecipitation and glutathione‐S‐transferase pull‐down assays were performed to examine the interaction between Fascin and acetyltransferase P300/CBP‐associated factor (PCAF), and immunofluorescence was used to investigate their colocalization. An in vitro acetylation assay was performed to identify Fascin acetylation sites by using mass spectrometry. A specific antibody against acetylated Fascin was generated and used to detect the PCAF‐mediated Fascin acetylation in esophageal squamous cell carcinoma (ESCC) cells using Western blotting by overexpressing and knocking down PCAF expression. An in vitro cell migration assay was performed, and a xenograft model was established to study in vivo tumor metastasis. Live‐cell imaging and fluorescence recovery after photobleaching were used to evaluate the function and dynamics of acetylated Fascin in filopodium formation. The clinical significance of acetylated Fascin and PCAF in ESCC was evaluated using immunohistochemistry. RESULTS: Fascin directly interacted and colocalized with PCAF in the cytoplasm and was acetylated at lysine 471 (K471) by PCAF. Using the specific anti‐AcK471‐Fascin antibody, Fascin was found to be acetylated in ESCC cells, and the acetylation level was consequently increased after PCAF overexpression and decreased after PCAF knockdown. Functionally, Fascin‐K471 acetylation markedly suppressed in vitro ESCC cell migration and in vivo tumor metastasis, whereas Fascin‐K471 deacetylation exhibited a potent oncogenic function. Moreover, Fascin‐K471 acetylation reduced filopodial length and density, and lifespan of ESCC cells, while its deacetylation produced the opposite effect. In the filipodium shaft, K471‐acetylated Fascin displayed rapid dynamic exchange, suggesting that it remained in its monomeric form owing to its weakened actin‐bundling activity. Clinically, high levels of AcK471‐Fascin in ESCC tissues were strongly associated with prolonged overall survival and disease‐free survival of ESCC patients. CONCLUSIONS: Fascin interacts directly with PCAF and is acetylated at lysine 471 in ESCC cells. Fascin‐K471 acetylation suppressed ESCC cell migration and tumor metastasis by reducing filopodium formation through the impairment of its actin‐bundling activity.
format Online
Article
Text
id pubmed-8696220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86962202022-01-04 P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer Cheng, Yin‐Wei Zeng, Fa‐Min Li, Da‐Jia Wang, Shao‐Hong He, Jian‐Zhong Guo, Zhen‐Chang Nie, Ping‐Juan Wu, Zhi‐Yong Shi, Wen‐Qi Wen, Bing Xu, Xiu‐E Liao, Lian‐Di Li, Zhi‐Mao Wu, Jian‐Yi Zhan, Jun Zhang, Hong‐Quan Chang, Zhi‐Jie Zhang, Kai Xu, Li‐Yan Li, En‐Min Cancer Commun (Lond) Original Articles BACKGROUND: Fascin is crucial for cancer cell filopodium formation and tumor metastasis, and is functionally regulated by post‐translational modifications. However, whether and how Fascin is regulated by acetylation remains unclear. This study explored the regulation of Fascin acetylation and its corresponding roles in filopodium formation and tumor metastasis. METHODS: Immunoprecipitation and glutathione‐S‐transferase pull‐down assays were performed to examine the interaction between Fascin and acetyltransferase P300/CBP‐associated factor (PCAF), and immunofluorescence was used to investigate their colocalization. An in vitro acetylation assay was performed to identify Fascin acetylation sites by using mass spectrometry. A specific antibody against acetylated Fascin was generated and used to detect the PCAF‐mediated Fascin acetylation in esophageal squamous cell carcinoma (ESCC) cells using Western blotting by overexpressing and knocking down PCAF expression. An in vitro cell migration assay was performed, and a xenograft model was established to study in vivo tumor metastasis. Live‐cell imaging and fluorescence recovery after photobleaching were used to evaluate the function and dynamics of acetylated Fascin in filopodium formation. The clinical significance of acetylated Fascin and PCAF in ESCC was evaluated using immunohistochemistry. RESULTS: Fascin directly interacted and colocalized with PCAF in the cytoplasm and was acetylated at lysine 471 (K471) by PCAF. Using the specific anti‐AcK471‐Fascin antibody, Fascin was found to be acetylated in ESCC cells, and the acetylation level was consequently increased after PCAF overexpression and decreased after PCAF knockdown. Functionally, Fascin‐K471 acetylation markedly suppressed in vitro ESCC cell migration and in vivo tumor metastasis, whereas Fascin‐K471 deacetylation exhibited a potent oncogenic function. Moreover, Fascin‐K471 acetylation reduced filopodial length and density, and lifespan of ESCC cells, while its deacetylation produced the opposite effect. In the filipodium shaft, K471‐acetylated Fascin displayed rapid dynamic exchange, suggesting that it remained in its monomeric form owing to its weakened actin‐bundling activity. Clinically, high levels of AcK471‐Fascin in ESCC tissues were strongly associated with prolonged overall survival and disease‐free survival of ESCC patients. CONCLUSIONS: Fascin interacts directly with PCAF and is acetylated at lysine 471 in ESCC cells. Fascin‐K471 acetylation suppressed ESCC cell migration and tumor metastasis by reducing filopodium formation through the impairment of its actin‐bundling activity. John Wiley and Sons Inc. 2021-09-23 /pmc/articles/PMC8696220/ /pubmed/34555274 http://dx.doi.org/10.1002/cac2.12221 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Cheng, Yin‐Wei
Zeng, Fa‐Min
Li, Da‐Jia
Wang, Shao‐Hong
He, Jian‐Zhong
Guo, Zhen‐Chang
Nie, Ping‐Juan
Wu, Zhi‐Yong
Shi, Wen‐Qi
Wen, Bing
Xu, Xiu‐E
Liao, Lian‐Di
Li, Zhi‐Mao
Wu, Jian‐Yi
Zhan, Jun
Zhang, Hong‐Quan
Chang, Zhi‐Jie
Zhang, Kai
Xu, Li‐Yan
Li, En‐Min
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title_full P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title_fullStr P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title_full_unstemmed P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title_short P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
title_sort p300/cbp‐associated factor (pcaf)‐mediated acetylation of fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696220/
https://www.ncbi.nlm.nih.gov/pubmed/34555274
http://dx.doi.org/10.1002/cac2.12221
work_keys_str_mv AT chengyinwei p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT zengfamin p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT lidajia p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT wangshaohong p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT hejianzhong p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT guozhenchang p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT niepingjuan p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT wuzhiyong p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT shiwenqi p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT wenbing p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT xuxiue p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT liaoliandi p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT lizhimao p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT wujianyi p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT zhanjun p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT zhanghongquan p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT changzhijie p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT zhangkai p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT xuliyan p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer
AT lienmin p300cbpassociatedfactorpcafmediatedacetylationoffascinatlysine471inhibitsitsactinbundlingactivityandtumormetastasisinesophagealcancer